共 50 条
- [3] The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1294 - 1303
- [5] Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M CELL REPORTS, 2014, 7 (06): : 1824 - 1832